Pneumonia clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for

  • Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

    open to eligible people ages 18 years and up

    BTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections. Potential subjects hospitalized with pneumonia or other infections are to be screened within 24 hours of diagnosis of ARDS.

    Irvine, California and other locations

Our lead scientists for Pneumonia research studies include .

Last updated: